Dipyanone is an opioid analgesic which has been sold as a designer drug, first identified in Germany in 2021.[1] It is closely related to medically used drugs such as methadone, dipipanone and phenadoxone, but is slightly less potent.[2][3]

Dipyanone
Identifiers
  • 4,4-diphenyl-6-(1-pyrrolidinyl)-heptan-3-one
CAS Number
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H29NO
Molar mass335.491 g·mol−1
3D model (JSmol)
  • CCC(=O)C(CC(C)N1CCCC1)(c1ccccc1)c1ccccc1

See also

edit

References

edit
  1. ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 1 November 2024). ISBN 978-92-9497-737-3.{{cite book}}: CS1 maint: DOI inactive as of November 2024 (link)
  2. ^ Ofner P, Walton E (1950). "444. Search for new analgesics. Part IV. Variations in the basic side-chain of amidone". Journal of the Chemical Society (Resumed): 2158. doi:10.1039/JR9500002158.
  3. ^ Lenz GR, Evans SM, Walters DE, Hopfinger AJ (1986). Opiates. Academic Press. pp. 406–407. ISBN 978-0-12-443830-9.